These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8780581)

  • 21. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
    van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
    Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator inhibitor-1 is expressed in cultured rat Sertoli cells.
    Le Magueresse-Battistoni B; Pernod G; Sigillo F; Kolodié L; Benahmed M
    Biol Reprod; 1998 Sep; 59(3):591-8. PubMed ID: 9716558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
    Heaton JH; Gelehrter TD
    Mol Endocrinol; 1989 Feb; 3(2):349-55. PubMed ID: 2469009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen activator inhibitor-1 messenger RNA expression is induced in rat hepatocytes in vivo by dexamethasone.
    Konkle BA; Schuster SJ; Kelly MD; Harjes K; Hassett DE; Bohrer M; Tavassoli M
    Blood; 1992 May; 79(10):2636-42. PubMed ID: 1375108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma.
    Cho SH; Tam SW; Demissie-Sanders S; Filler SA; Oh CK
    J Immunol; 2000 Sep; 165(6):3154-61. PubMed ID: 10975829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines.
    Halleux CM; Declerck PJ; Tran SL; Detry R; Brichard SM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4097-105. PubMed ID: 10566656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin regulation of tissue type plasminogen activator and plasminogen activator inhibitor type-I gene expression in eCG-primed rat granulosa cells in culture.
    Liu YX; Peng XR; Liu HZ; Chen YJ; Ny T
    Biol Reprod; 1998 Aug; 59(2):409-16. PubMed ID: 9687315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of plasminogen activator inhibitor-1 release from human cerebral endothelium by plasminogen activators. A factor potentially predisposing to intracranial bleeding.
    Shatos MA; Doherty JM; Penar PL; Sobel BE
    Circulation; 1996 Aug; 94(4):636-42. PubMed ID: 8772682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells.
    Wilson HM; Haites NE; Booth NA
    Exp Nephrol; 1997; 5(3):233-8. PubMed ID: 9208283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
    Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
    Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
    Bergheim I; Guo L; Davis MA; Duveau I; Arteel GE
    J Pharmacol Exp Ther; 2006 Feb; 316(2):592-600. PubMed ID: 16221737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X; Li C; Li X; Cai L
    Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of tissue-type plasminogen activator (tPA) and type-1 plasminogen activator inhibitor (PAI-1) as early growth responses in rat hepatocytes in primary culture.
    Uno S; Nakamura M; Seki T; Ariga T
    Biochem Biophys Res Commun; 1997 Oct; 239(1):123-8. PubMed ID: 9345281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of plasminogen activation in rat cell lines.
    Reinders JH; Kaczmarek P; van Giezen JJ; Jansen JW
    Ann N Y Acad Sci; 1992 Dec; 667():194-8. PubMed ID: 1285021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes.
    Heaton JH; Nebes VL; O'Dell LG; Morris SM; Gelehrter TD
    Mol Endocrinol; 1989 Jan; 3(1):185-92. PubMed ID: 2536889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
    Gesualdo L; Ranieri E; Monno R; Rossiello MR; Colucci M; Semeraro N; Grandaliano G; Schena FP; Ursi M; Cerullo G
    Kidney Int; 1999 Aug; 56(2):461-70. PubMed ID: 10432384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells.
    Watanabe A; Kurabayashi M; Arai M; Sekiguchi K; Nagai R
    Cardiovasc Res; 2001 Jul; 51(1):151-9. PubMed ID: 11399257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.